Latest Acquisitions News

Acrow Limited reported a 4% rise in underlying net profit for FY25, driven by strategic acquisitions and a growing industrial access division now contributing half of group revenue. Despite some formwork delays, the company maintains a strong project pipeline and steady dividends.

Trigg Minerals has expanded its Tennessee Mountain Tungsten Project in Nevada by acquiring contiguous claims that consolidate a district-scale mineralised system, setting the stage for modern exploration and resource definition.

Alkane Resources reports a strong first quarter for FY2026, driven by its recent acquisition of Mandalay Resources, boosting gold equivalent production and revenue significantly.

Alkane Resources reports its Q1 FY2026 interim results, highlighting the integration of Mandalay Resources and key operational developments across its global mining portfolio.

Suzerain Investment Holdings Ltd has initiated an off-market takeover offer for all remaining shares in Entertainment Rewards Ltd at a significant premium, aiming to consolidate full ownership and potentially delist the company from the ASX.

The Supreme Court of Western Australia has approved the share and option schemes for Capricorn Metals’ acquisition of Warriedar Resources, setting the stage for a significant consolidation in the gold exploration sector.

Tombador Iron Limited has completed its strategic acquisition of GoviEx Uranium Inc., paving the way for a relisting as Atomic Eagle Ltd focused on uranium exploration.

The Foreign Investment Review Board has extended its deadline for approving Mayne Pharma's acquisition by Cosette Pharmaceuticals, maintaining the current transaction timetable for now.

Tombador Iron Limited reports a quarterly loss amid a strategic acquisition of GoviEx Uranium, signaling a pivot to uranium exploration and a rebrand to Atomic Eagle Limited.

Volt Group Limited is set to acquire Perth-based 4D Delta Pty Ltd for $7.25 million, adding a profitable digital asset inspection business to its portfolio. The acquisition is supported by a $4 million capital raise and aims to accelerate Volt’s growth in technology-enabled resource services.

Resonance Health has revealed ambitious growth plans at its 2025 AGM, projecting revenue to nearly quadruple by FY26 while maintaining positive EBITDA guidance. The company is broadening its global footprint and diversifying its clinical trial services across multiple therapeutic areas.

Volt Group Limited has locked in a conditional $4 million placement to support its acquisition of 4D Delta, backed by strong institutional and director participation. The raise, priced at a discount to recent trading, aims to accelerate growth initiatives and strengthen working capital.